Evidence for a Physiological Role of Hypothalamic Gastrin-releasing Peptide to Suppress Growth Hormone and Prolactin Release in the Rat

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1988 Feb 1

PMID 3422472

Citations 4

Authors

S Kentroti

W L Dees

S M McCANN

Affiliations

Soon will be listed here.

Abstract

Gastrin-releasing peptide (GRP) is localized to hypothalamic neurons and is a potent inhibitor of basal and growth hormone (GH)-releasing factor-induced GH secretion in the rat. It also acts similarly to inhibit opiate- and stress-induced prolactin (PRL) release. To determine the physiological significance of the peptide in the control of the release of these two hormones, a highly specific antiserum against GRP was injected into the third brain ventricle to immunoneutralize hypothalamic GRP. The injection of the antiserum initially did not alter levels of the hormones; however, both PRL and GH levels in the plasma began to increase within 3 and 3.5 hr, respectively. They were still significantly elevated 24 hr after the injection. There was no change in the plasma levels of either hormone in animals injected intraventricularly with a similar volume of normal rabbit serum (NRS). Mean plasma GH levels 24 hr after antiserum injection were more than twice those of the NRS-injected controls, whereas the PRL concentrations were 14-fold higher in the antiserum injected as compared to the control NRS-injected animals. A second similar injection of antiserum 24 hr after the first administration resulted in a slight and transient further increase in both GH and PRL levels so that they were both significantly (P less than 0.001) higher than those of the animals given a second injection of NRS. The anti-GRP antiserum was highly specific for GRP by radioimmunoassay procedures and this antiserum produced positive immunostaining of GRP neuronal perikarya and terminals within discrete hypothalamic nuclei. Beaded fibers and terminals were observed in the suprachiasmatic nucleus (SCN) and the area lateral and dorsal to the SCN in the region of the periventricular nucleus (PeVN). GRP-positive perikarya were observed in the parvocellular neurons of the paraventricular nucleus. In addition, GRP-positive cell bodies were observed in the PeVN in close proximity to the third ventricle. Furthermore, the median eminence displayed no immunostaining for GRP, and all traces of positive staining were abolished by preabsorption of the antiserum with GRP-27 (30 micrograms/ml), confirming the specificity of the antiserum. The combined results with immunoneutralization of GRP and the immunostaining of GRP neuronal elements in the hypothalamus support the physiological role of this peptide in the inhibitory control of both GH and PRL release.

Citing Articles

Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Chile T, Correa-Giannella M, Fortes M, Bronstein M, Cunha-Neto M, Giannella-Neto D J Endocrinol Invest. 2011; 34(8):e214-8.

PMID: 21270509 DOI: 10.3275/7481.

Water intake in rats subjected to hypothalamic immunoneutralization of angiotensin II, atrial natriuretic peptide, vasopressin, or oxytocin.

Franci C, Kozlowski G, McCANN S Proc Natl Acad Sci U S A. 1989; 86(8):2952-6.

PMID: 2523076 PMC: 287038. DOI: 10.1073/pnas.86.8.2952.

Role of neuromedin B in the control of the release of thyrotropin in the rat.

Rettori V, Milenkovic L, Fahim A, Polak J, Bloom S, McCANN S Proc Natl Acad Sci U S A. 1989; 86(12):4789-92.

PMID: 2499891 PMC: 287359. DOI: 10.1073/pnas.86.12.4789.

Gastrin-releasing peptide in human nasal mucosa.

Baraniuk J, Lundgren J, Goff J, Peden D, MERIDA M, Shelhamer J J Clin Invest. 1990; 85(4):998-1005.

PMID: 2318984 PMC: 296528. DOI: 10.1172/JCI114577.

References

Harms P, Ojeda S . A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol. 1974; 36(3):391-2. DOI: 10.1152/jappl.1974.36.3.391. View

Kita T, Chihara K, Abe H, Minamitani N, Kaji H, Kodama H . Regional distribution of gastrin-releasing peptide- and somatostatin-like immunoreactivity in the rabbit hypothalamus. Brain Res. 1986; 398(1):18-22. DOI: 10.1016/0006-8993(86)91245-x. View

Wakabayashi I, Miyazawa Y, Kanda M, Miki N, DEMURA R, Demura H . Stimulation of immunoreactive somatostatin release from hypothalamic synaptosomes by high (K+) and dopamine. Endocrinol Jpn. 1977; 24(6):601-4. DOI: 10.1507/endocrj1954.24.601. View

McDonald T, Nilsson G, VAGNE M, Ghatei M, Bloom S, Mutt V . A gastrin releasing peptide from the porcine nonantral gastric tissue. Gut. 1978; 19(9):767-74. PMC: 1412172. DOI: 10.1136/gut.19.9.767. View

Negro-Vilar A, Ojeda S, Arimura A, McCANN S . Dopamine and norepinephrine stimulate somatostatin release by median eminence fragments in vitro. Life Sci. 1978; 23(14):1493-7. DOI: 10.1016/0024-3205(78)90131-5. View

Tache Y, Brown M, Collu R . Effects of neuropeptides on adenohypophyseal hormone response to acute stress in male rats. Endocrinology. 1979; 105(1):220-4. DOI: 10.1210/endo-105-1-220. View

Moody T, Pert C . Bombesin-like peptides in rat brain: quantitation and biochemical characterization. Biochem Biophys Res Commun. 1979; 90(1):7-14. DOI: 10.1016/0006-291x(79)91582-1. View

Tache Y, Pittman Q, Brown M . Bombesin-induced poikilothermy in rats. Brain Res. 1980; 188(2):525-30. DOI: 10.1016/0006-8993(80)90050-5. View

Tache Y, MARKI W, Rivier J, Vale W, Brown M . Central nervous system inhibition of gastric secretion in the rat by gastrin-releasing peptide, a mammalian bombesin. Gastroenterology. 1981; 81(2):298-302. View

10.

Kulkosky P, Gibbs J, Smith G . Behavioral effects of bombesin administration in rats. Physiol Behav. 1982; 28(3):505-12. DOI: 10.1016/0031-9384(82)90147-0. View

11.

Roth K, Weber E, Barchas J . Distribution of gastrin releasing peptide--bombesin-like immunostaining in rat brain. Brain Res. 1982; 251(2):277-82. DOI: 10.1016/0006-8993(82)90744-2. View

12.

Stein L, Woods S . Gastrin releasing peptide reduces meal size in rats. Peptides. 1982; 3(5):833-5. DOI: 10.1016/0196-9781(82)90023-7. View

13.

Matsushita N, Kato Y, Katakami H, Shimatsu A, Yanaihara N, Imura H . Inhibition of prolactin secretion by gastrin releasing peptide (GRP) in the rat. Proc Soc Exp Biol Med. 1983; 172(1):118-21. DOI: 10.3181/00379727-172-1-rc1. View

14.

Tsutsumi Y, Osamura R, Watanabe K, Yanaihara N . Immunohistochemical studies on gastrin-releasing peptide- and adrenocorticotropic hormone-containing cells in the human lung. Lab Invest. 1983; 48(5):623-32. View

15.

Inoue K, McKay D, Yajima H, Rayford P . Effect of synthetic porcine gastrin-releasing peptide on plasma levels of immunoreactive cholecystokinin pancreatic polypeptide and gastrin in dogs. Peptides. 1983; 4(2):153-7. DOI: 10.1016/0196-9781(83)90106-7. View

16.

Kulik T, Johnson D, Elde R, Lock J . Pulmonary vascular effects of bombesin and gastrin-releasing peptide in conscious newborn lambs. J Appl Physiol Respir Environ Exerc Physiol. 1983; 55(4):1093-7. DOI: 10.1152/jappl.1983.55.4.1093. View

17.

Moghimzadeh E, Ekman R, Hakanson R, Yanaihara N, Sundler F . Neuronal gastrin-releasing peptide in the mammalian gut and pancreas. Neuroscience. 1983; 10(2):553-63. DOI: 10.1016/0306-4522(83)90152-5. View

18.

Bloom S, Edwards A, Ghatei M . Endocrine responses to exogenous bombesin and gastrin releasing peptide in conscious calves. J Physiol. 1983; 344:37-48. PMC: 1193823. DOI: 10.1113/jphysiol.1983.sp014922. View

19.

Costa M, Furness J, Yanaihara N, Yanaihara C, Moody T . Distribution and projections of neurons with immunoreactivity for both gastrin-releasing peptide and bombesin in the guinea-pig small intestine. Cell Tissue Res. 1984; 235(2):285-93. DOI: 10.1007/BF00217852. View

20.

Kabayama Y, Kato Y, Shimatsu A, Ohta H, Yanaihara N, Imura H . Inhibition by gastrin-releasing peptide of growth hormone (GH) secretion induced by human pancreatic GH-releasing factor in rats. Endocrinology. 1984; 115(2):649-53. DOI: 10.1210/endo-115-2-649. View